Monocyte cytotoxicity during acute kidney graft rejection in rats

International Immunology

Volumn 16, Issue 1, 2004, Pages 101-110

  Stehling, Oliver ^a   Grau, Veronika ^b   Steiniger, Birte ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Apoptosis; CD161; Flow cytometry; Necrosis; Transplantation

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; MEROCYANINE; NITRIC OXIDE; PROPIDIUM IODIDE;

ACUTE GRAFT REJECTION; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ASSAY; CELL DAMAGE; CELL LABELING; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; FLOW CYTOMETRY; KIDNEY ALLOGRAFT REJECTION; KIDNEY BLOOD VESSEL; KIDNEY TRANSPLANTATION; LYMPHOMA CELL LINE; MALE; MASTOCYTOMA; MONOCYTE; MOUSE; NATURAL KILLER CELL; NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECIPIENT; SENSITIVITY ANALYSIS; TARGET CELL;

ANIMALS; ANTIGENS, SURFACE; CALCIUM; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; EXTRACELLULAR FLUID; FLOW CYTOMETRY; GRAFT REJECTION; KIDNEY TRANSPLANTATION; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MALE; MONOCYTES; RATS;

EID: 0347359050     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh007     Document Type: Article

References (53)

1. Joyce, D. A., Steer, J. H. and Abraham, L. J. 1997. Glucocorticoid modulation of human monocyte/macrophage function: control of TNF-alpha secretion. Inflamm. Res. 46:447.
2. Nakayama, M., Ishidoh, K., Kayagaki, N., Kojima, Y., Yamaguchi, N., Nakano, H., Kominami, E., Okumura, K. and Yagita, H. 2002. Multiple pathways of TWEAK-induced cell death. J. Immunol. 168:734.
3. Bogdan, C., Rollinghoff, M. and Diefenbach, A. 2000. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12:64.
4. Nathan, C. F. 1987. Secretory products of macrophages. J. Clin. Invest. 79:319.
5. Selsted, M. E. and Ouellette, A. J. 1995. Defensins in granules of phagocytic and non-phagocytic cells. Trends Cell Biol. 5:114.
6. Colvin, R. B. 1990. Cellular and molecular mechanisms of allograft rejection. Annu. Rev. Med. 41:361.
7. Gracie, J. A., Bolton, E. M., Porteous, C. and Bradley, J. A. 1990. T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity. J. Exp. Med. 172:1547.
8. Markus, P. M., van den Brink, M. R., Cai, X., Harnaha, J., Palomba, L., Hiserodt, J. C. and Cramer, D. V. 1991. Effect of selective depletion of natural killer cells on allograft rejection. Transplant. Proc. 23:178.
9. Grau, V., Herbst, B. and Steiniger, B. 1998. Dynamics of monocytes/macrophages and T lymphocytes in acutely rejecting rat renal allografts. Cell Tissue Res. 291:117.
10. Raftery, M. J., Seron, D., Koffman, G., Hartley, B., Janossy, G. and Cameron, J. S. 1989. The relevance of induced class II HLA antigens and macrophage infiltration in early renal allograft biopsies. Transplantation 48:238.
11. Barclay, A. N., Wright, G. J., Brooke, G. and Brown, M. H. 2002. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol. 23:285.
12. Grau, V., Stehling, O., Garn, H. and Steiniger, B. 2001. Accumulating monocytes in the vasculature of rat renal allografts: phenotype, cytokine, inducible NO synthase, and tissue factor mRNA expression. Transplantation 71:37.
13. Grau, V., Gemsa, D., Steiniger, B. and Garn, H. 2000. Chemokine expression during acute rejection of rat kidneys. Scand. J. Immunol. 51:435.
14. Adams, S., van der Laan LJ, Vernon-Wilson, E., Renardel, d. L., Dopp, E. A., Dijkstra, C. D., Simmons, D. L. and van den Berg TK. 1998. Signal-regulatory protein is selectively expressed by myeloid and neuronal cells. J. Immunol. 161:1853.
15. Scriba, A., Grau, V. and Steiniger, B. 1998. Phenotype of rat monocytes during acute kidney allograft rejection: increased expression of NKR-P1 and reduction of CD43. Scand. J. Immunol. 47:332.
16. Scriba, A., Schneider, M., Grau, V., van der Meide PH, and Steiniger, B. 1997. Rat monocytes up-regulate NKR-P1A and down-modulate CD4 and CD43 during activation in vivo: monocyte subpopulations in normal and IFN-gamma-treated rats. J. Leukoc. Biol. 62:741.
17. Chambers, W. H., Vujanovic, N. L., DeLeo, A. B., Olszowy, M. W., Herberman, R. B. and Hiserodt, J. C. 1989. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J. Exp. Med. 169:1373.
18. Lanier, L. L. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359.
19. + T cells and natural killer cells share expression of NKR-P1A and NKR-P1D. Nat. Immunol. 15:259.
20. Plougastel, B., Matsumoto, K., Dubbelde, C. and Yokoyama, W. M. 2001. Analysis of a 1-Mb BAC contig overlapping the mouse Nkrp1 cluster of genes: cloning of three new Nkrp1 members, Nkrp1d, Nkrp1e, and Nkrp1f. Immunogenetics 53:592.
21. Li, J., Rabinovich, B. A., Hurren, R., Shannon, J. and Miller, R. G. 2003. Expression cloning and function of the rat NK activating and inhibitory receptors NKR-P1A and -P1B. Int. Immunol. 15:411.
22. Sanchez-Bueno, A., Verkhusha, V., Tanaka, Y., Takikawa, O. and Yoshida, R. 1996. Interferon-gamma-dependent expression of inducible nitric oxide synthase, interleukin-12, and interferon-gamma-inducing factor in macrophages elicited by allografted tumor cells. Biochem. Biophys. Res. Commun. 224:555.
23. Yamamoto, N., Einaga-Naito, K., Kuriyama, M., Kawada, Y. and Yoshida, R. 1998. Cellular basis of skin allograft rejection in mice: specific lysis of allogeneic skin components by non-T cells. Transplantation 65:818.
24. Fabre, J., Lim, S. H. and Morris, P. J. 1971. Renal transplantation in the rat: details of a technique. Aust. NZ J. Surg. 41:69.
25. Scriba, A., Luciano, L. and Steiniger, B. 1996. High-yield purification of rat monocytes by combined density gradient and immunomagnetic separation. J. Immunol. Methods 189:203.
26. Axberg, I., Nose, M., Reynolds, C. W. and Wigzell, H. 1988. Features of the in vitro established rat large granular lymphocyte leukaemia RNK-16. Scand. J. Immunol. 27:271.
27. Cui, S., Reichner, J. S., Mateo, R. B. and Albina, J. E. 1994. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res. 54:2462.
28. Reske, K., Mohle, U., Sun, D. and Wekerle, H. 1987. Synthesis and cell surface display of class II determinants by long- term propagated rat T line cells. Eur. J. Immunol. 17:909.
29. Stehling, O., Grau, V. and Steiniger, B. 2003. Cytotoxicity of normal and activated rat monocytes analyzed by flow cytometry. Cytometry 00:00.
30. Voltarelli, J. C., Rayner, A. A., Garovoy, M. R. and Stites, D. P. 1990. Human spleen and peripheral blood lymphocytes activated by interleukin-2 have similar phenotypic and functional characteristics. J. Biol. Response Mod. 9:103.
31. Shaw, S. G., Maung, A. A., Steptoe, R. J., Thomson, A. W. and Vujanovic, N. L. 1998. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy. J. Immunol. 161:2817.
32. Laakko, T., King, L. and Fraker, P. 2002. Versatility of merocyanine 540 for the flow cytometric detection of apoptosis in human and murine cells. J. Immunol. Methods 261:129.
33. Vitale, M., Zamai, L., Mazzotti, G., Cataldi, A. and Falcieri, E. 1993. Differential kinetics of propidium iodide uptake in apoptotic and necrotic thymocytes. Histochemistry 100:223.
34. Shresta, S., Pham, C. T., Thomas, D. A., Graubert, T. A. and Ley, T. J. 1998. How do cytotoxic lymphocytes kill their targets? Curr. Opin. Immunol. 10:581.
35. Ryan, J. C., Niemi, E. C., Nakamura, M. C. and Seaman, W. E. 1995. NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity. J. Exp. Med. 181:1911.
36. 2+-dependent mechanism. J. Exp. Med. 186:467.
37. 2+-dependent, Fas- and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage. J. Immunol. 159:15.
38. Majno, G. and Joris, I. 1995. Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol. 146:3.
39. Higashi, N., Taki, H., Nishimura, Y., Higuchi, M. and Osawa, T. 1993. Chromium and tritiated thymidine releases from target cells are differential events in human monocyte/macrophage-mediated cytotoxicity. Cell. Immunol. 150:333.
40. Aliprantis, A. O., Diezroux, G., Mulder, L. C. F., Zychlinsky, A. and Lang, R. A. 1996. Do macrophages kill through apoptosis? Immunol. Today 17:573.
41. Morel, D., Normand, E., Lemoine, C., Merlio, J. P., Velours, J., Astier, T., Bonnet, F., Aparicio, M., Potaux, L. and Bloch, B. 1993. Tumor necrosis factor alpha in human kidney transplant rejection-analysis by in situ hybridization. Transplantation 55:773.
42. Duffield, J. S., Erwig, L. P., Wei, X., Liew, F. Y., Rees, A. J. and Savill, J. S. 2002. Activated macrophages direct apoptosis and suppress mitosis of mesangial cells. J. Immunol. 164:2110.
43. Hiserodt, J. C., Britvan, L. J. and Targan, S. R. 1982. Characterization of the cytolytic reaction mechanism of the human natural killer (NK) lymphocyte: resolution into binding, programming, and killer cell-independent steps. J. Immunol. 129:1782.
44. Hille, B., Billiard, J., Babcock, D. F., Nguyen, T. and Koh, D. S. 1999. Stimulation of exocytosis without a calcium signal. J. Physiol. 520:23.
45. Matsumoto, G., Nghiem, M. P., Nozaki, N., Schmits, R. and Penninger, J. M. 1998. Cooperation between CD44 and LFA-1/CD11a adhesion receptors in lymphokine-activated killer cell cytotoxicity. J. Immunol. 160:5781.
46. Binnerts, M. E. and van Kooyk, Y. 1999. How LFA-1 binds to different ligands. Immunol. Today 20:240.
47. King, M. A. and Radicchi-Mastroianni, M. A. 1996. Use of four-colour flow cytometry to evaluate conjugate formation between human peripheral blood mononuclear cells and tumour target cells. Cytometry 24:368.
48. Lanier, L. L., Chang, C. and Phillips, J. H. 1994. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J. Immunol. 153:2417.
49. Poggi, A., Rubartelli, A., Moretta, L. and Zocchi, M. R. 1997. Expression and function of NKRP1A molecule on human monocytes and dendritic cells. Eur. J. Immunol. 27:2965.
50. Hundrieser, J., Düvel, H., Dinkel, A., Hänisch, L., Trautewig, B., Blasczyk, R., Lambracht-Washington, D. and Wonigeit, K. 2002. Genetic polymorphism of the inhibitory NKR-P1B receptor in the rat. Immunobiology 206:96.
51. Scriba, A., Grau, V., Celik, I., Stehling, O., Schneider, M. and Steiniger, B. 1997. Expression of NKR-P1, CD8 and CD43 by rat monocytes during severe immune reactions in vivo. Immunobiology 197:226
52. Ryan, J. C., Niemi, E. C., Goldfien, R. D., Hiserodt, J. C. and Seaman, W. E. 1991. NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium. J. Immunol. 147:3244.
53. Bezouska, K., Yuen, C. T., O'Brien, J., Childs, R. A., Chai, W., Lawson, A. M., Drbal, K., Fiserova, A., Pospisil, M. and Feizi, T. 1994. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 372:150.